EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Postoperative exclusive enteral nutrition as a bridging therapy to reduce endoscopic recurrence after intestinal resection in Crohn’s disease: A randomized controlled trial

Mengting Zhang, Qianwen Tu, Kangcheng Luo, Daojiang Li, Songlin Wan, Zhaoyang Cai, Xianghai Ren, Yi Li, Yi Liu, Mei Ye, Min Chen, Zhao Ding

Clinical Nutrition · 2026-01 · 56 · 106545

DOI: 10.1016/j.clnu.2025.106545 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2026-01. Verfasst von Mengting Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University,…. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Postoperative Care, Postoperative Complications. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Zhongnan Hospital of Wuhan University, Wu Jieping Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Postoperative recurrence remains a significant challenge in Crohn's disease (CD) despite surgical intervention. While exclusive enteral nutrition (EEN) has demonstrated anti-inflammatory effects, its role in preventing postoperative recurrence remains underexplored. This study aimed to evaluate whether postoperative EEN reduces endoscopic recurrence at 1 year in CD patients after bowel resection. METHODS: This was a single center, open-label and randomized controlled trial. Using fixed block randomization, 100 participants were randomly assigned (1:1) to the normal diet group (unrestricted food intake) or the EEN group (receiving exclusive enteral formula for ≥2 months). The primary endpoint was endoscopic recurrence at 1 year after surgery (Rutgeerts score ≥ i2). Secondary endpoints included biochemical markers, postoperative complications, and quality of life. RESULTS: Overall, 100 participants were assessed for eligibility and randomly assigned to receive a normal diet (n = 50) or EEN (n = 50). All randomized participants were included in the intention-to-treat analysis. Compared to the normal diet group, the EEN group demonstrated a significantly lower postoperative endoscopic recurrence rate at 1 year (38 % [19/50] vs 18 % [9/50]; RR, 0.474; 95 % CI, 0.238-0.944; P = 0.026) and lower postoperative C-reactive protein at 2 months (median [IQR]:3.5 [0,7.75] mg/L vs 1 [1,2] mg/L, P = 0.034). No significant differences were observed in quality of life and 30-day/late-term postoperative complication rates (P > 0.05) and no adverse events occurred between groups. CONCLUSION: Postoperative EEN (≥2 months) significantly reduces the risk of endoscopic recurrence at 1 year in CD patients after resection. Additionally, CD patients showed high adherence to the oral EEN regimen after surgery. CLINICAL TRIAL REGISTRATION: ChinaClinicalTrial.gov (Number: ChiCTR2400081066).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseEnteral NutritionPostoperative CarePostoperative ComplicationsSecondary PreventionHumansMaleFemaleAdultMiddle AgedRecurrenceQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

Crohn’s diseaseExclusive enteral nutritionPostoperative endoscopic recurrenceSurgery

Autor:innen und Institutionen

  • Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: dingzhao@whu.edu.cn.

Förderung

  • Zhongnan Hospital of Wuhan University
  • Wu Jieping Medical Foundation

Zitieren

APA

Zhang, M., Tu, Q., Luo, K., Li, D., Wan, S., Cai, Z., Ren, X., Li, Y., Liu, Y., Ye, M., Chen, M., & Ding, Z. (2026). Postoperative exclusive enteral nutrition as a bridging therapy to reduce endoscopic recurrence after intestinal resection in Crohn’s disease: A randomized controlled trial. Clinical Nutrition, 56, 106545. https://doi.org/10.1016/j.clnu.2025.106545

Vancouver

Zhang M, Tu Q, Luo K, Li D, Wan S, Cai Z, et al. Postoperative exclusive enteral nutrition as a bridging therapy to reduce endoscopic recurrence after intestinal resection in Crohn’s disease: A randomized controlled trial. Clinical Nutrition. 2026;56:106545. doi:10.1016/j.clnu.2025.106545

BibTeX
@article{Zhang2026,
  author = {Zhang, Mengting and Tu, Qianwen and Luo, Kangcheng and Li, Daojiang and Wan, Songlin and Cai, Zhaoyang and Ren, Xianghai and Li, Yi and Liu, Yi and Ye, Mei and Chen, Min and Ding, Zhao},
  title = {Postoperative exclusive enteral nutrition as a bridging therapy to reduce endoscopic recurrence after intestinal resection in Crohn’s disease: A randomized controlled trial},
  journal = {Clinical Nutrition},
  year = {2026},
  volume = {56},
  pages = {106545},
  doi = {10.1016/j.clnu.2025.106545}
}
Kostenlos starten →